Streetbeat News

Products Services

KTOS

Kratos Defense & Security Solutions (NASDAQ:KTOS) and Clearbox Systems have signed a collaboration agreement to co-develop and co-market solutions for software-defined satellite ground systems. Clearbox will integrate its Foresight product with Kratos' OpenSpace platform, and both companies will work together to deliver Space Domain Awareness solutions.

Portfolio Pulse from Happy Mohamed

May 22, 2023 | 12:38 pm

GM

General Motors (GM) has confirmed plans to introduce an all-electric version of its flagship Cadillac Escalade later this year.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:37 pm

JFBR

Jeffs' Brands shares are trading higher after the company announced successful reduction in time and costs for launching new products on Amazon Marketplace using ChatGPT and other AI-based tools.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:37 pm

NBSE

NeuBase Therapeutics reported positive preclinical safety and efficiency data for its Stealth Editors development program, demonstrating gene editing with a non-immunogenic system.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:36 pm

JFBR

Jeffs' Brands reports successful reduction in time and costs for launching new products on Amazon Marketplace using ChatGPT and other AI-based tools.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:34 pm

FXI

China's gaming regulator has granted approval for 86 domestic online games in May, including titles from Tencent and NetEase. This comes after a nine-month freeze on approvals in 2018.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:32 pm

BTCUSD

In 2010, Laszlo Hanyecz purchased two pizzas using 10,000 Bitcoin (BTC), marking the first-ever recorded real-world transaction with cryptocurrency. Today, those 10,000 BTC would be worth over $267.91 million.

Portfolio Pulse from Mehab Qureshi

May 22, 2023 | 12:31 pm

IMMX

Immix Biopharma announced positive clinical results for NXC-201, showing a 100% overall response rate in DARZALEX-relapsed or refractory AL amyloidosis patients in the ongoing NEXICART-1 Phase 1b/2a trial.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:29 pm

PBLA

Panbela announced a clinical trial in collaboration with Moffitt Cancer Center for a Phase I/II program targeting STK11 mutant non-small cell lung cancer. The trial aims to evaluate the safety and efficacy of Panbela's drug candidate.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:26 pm

KULR

KULR Technology Group expects substantial revenue growth compared to Q1 2023 due to sizable demand for its KULR One battery packs.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2023 | 12:24 pm